Clicky

Qiagen N.V.(QGEN)

Description: QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.


Keywords: Biotechnology Biology Molecular Biology Acid Molecular Diagnostics Laboratory Techniques Scanner Consumable Products Food Safety Cloning Polymerase Chain Reaction Lab Testing Transcription DNA Sequencing Pharmaceutical Research HPV Genome Papillomavirus Technology Licensing Companion Diagnostic Qiagen Real Time Polymerase Chain Reaction Instrumentation Systems Forensics Protein Purification Nucleic Acid Methods

Home Page: www.qiagen.com

QGEN Technical Analysis

Hulsterweg 82
Venlo, 5912 PL
Netherlands
Phone: 31 77 355 6600


Officers

Name Title
Mr. Thierry Bernard CEO, MD & Member of Management Board
Dr. Roland Sackers CFO, MD & Member of Management Board
Mr. Antonio Santos Sr. VP & Head of Global Operations
Mr. John Gilardi VP of Corp. Communications & Investor Relations
Ms. Stephany Foster Sr. VP & Head of HR
Dr. Thomas Schweins Sr. VP of Life Science Bus. Area
Dr. Thomas Theuringer Sr. Director & Head of External Communications
Mr. Jean-Pascal Viola Sr. VP & Head of Molecular Diagnostics Bus. Area
Dr. Jonathan G. Sheldon Ph.D. Sr. VP of Qiagen Digital Insights Bus. Area
Mr. Thomas Neidert VP of Global Treasury

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 23.753
Trailing PE: 25.14
Price-to-Book MRQ: 3.4048
Price-to-Sales TTM: 5.1004
IPO Date: 1996-06-28
Fiscal Year End: December
Full Time Employees: 6200
Back to stocks